LL-37 and TB-500 Interaction
LL-37 and TB-500 have a synergistic interaction with 95% confidence. Combined anti-inflammatory and healing effects. Both compounds affect the blood vessels, so monitoring these systems is recommended.
Compound Profiles
LL-37
Human Cathelicidin | Antimicrobial Peptide
Provides direct antimicrobial activity through membrane disruption, promotes wound healing by enhancing keratinocyte migration and angiogenesis, and modulates immune responses without systemic exposure when used topically..
View full profileTB-500
Synthetic Fragment (17-23) of Thymosin Beta-4
Acts as principal actin-sequestering protein, regulating cell migration, promoting angiogenesis, reducing inflammation, and activating stem cell differentiation for comprehensive regenerative effects..
View full profileCombined Organ Load
Frequently Asked Questions
Can I take LL-37 with TB-500?
Yes, LL-37 and TB-500 can generally be taken together. Combined anti-inflammatory and healing effects.
Is LL-37 and TB-500 safe together?
Based on documented research, this combination is considered synergistic. No critical safety flags identified for this pair.
What are the interactions between LL-37 and TB-500?
Combined anti-inflammatory and healing effects. This assessment has 95% confidence and is based on documented research data.
How should I time LL-37 and TB-500?
LL-37 has a half-life of Short (rapid proteolytic degradation) and TB-500 has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.